Raymond James reiterates Market Perform rating on Bumble stock

Bumble Inc. (BMBL) reported mixed second-quarter results, with a significant EPS miss of -$2.45 against an anticipated $0.34, despite slightly exceeding revenue forecasts and achieving year-over-year ARPPU growth for the first time since Q2 2022 by strategically reducing lower-value users. Raymond James reiterated its Market Perform rating, maintaining a neutral stance and advising investors to await concrete evidence of the company's detailed quality-focused turnaround strategy gaining traction, even as the stock remained stable post-earnings.

Analysis

Bumble Inc. presents a mixed financial profile following its second-quarter results, characterized by a significant divergence between profitability and top-line performance. The company reported a substantial earnings per share (EPS) miss of -$2.45 against a forecast of $0.34, an -822.5% surprise that signals severe pressure on profitability. Despite this, revenue slightly exceeded expectations at $248 million versus a $244.17 million consensus, and the stock price remained stable, suggesting investors are weighing top-line resilience against the earnings shortfall. A key strategic development is the intentional reduction in paying users, which the company attributes to phasing out a promotional program to improve user quality. This pivot is supported by the first year-over-year growth in Average Revenue Per Paying User (ARPPU) for the Bumble App since Q2 2022. However, the full impact of its quality-focused turnaround remains distant, with major product launches scheduled for August 2025 and February 2026. Consequently, Raymond James has reiterated its neutral 'Market Perform' rating, adopting a cautious stance until tangible evidence confirms the new strategy is effectively engaging users.

Key Decisions for Investors

• Investors should monitor for sustained growth in Average Revenue Per Paying User (ARPPU) and a stabilization in the paying user base in subsequent quarters to validate the effectiveness of the company's quality-over-quantity strategy.
• Given the significant EPS miss, future earnings reports must be scrutinized for improved profitability, as the market's current focus on stable revenue may not persist if margin pressures continue.
• With key product rollouts not scheduled until August 2025 and February 2026, a patient, hold-rated approach is warranted, as catalysts for significant share price appreciation appear to be on a long-term horizon, reflecting the cautious stance of analysts like Raymond James.